Position in NVS
as of Mar 31, 2026
· filed Apr 17, 2026
Position Value
$214,155
-$15,937 QoQ
Shares Held
1,402
-43.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cornell Pochily Investment Advisors, Inc. holds $19,372,779 across 8 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
24,344 | $6,125,924 | |
| 2 | JNJ |
Johnson & Johnson
|
18,975 | $4,819,080 | |
| 3 | AMGN |
Amgen Inc
|
7,009 | $2,538,099 | |
| 4 | LLY |
ELI LILLY & Co
|
1,708 | $2,048,626 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
10,724 | $1,354,870 | |
| 6 | MRK |
Merck & Co., Inc.
|
8,019 | $1,030,441 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
13,451 | $775,046 | |
| 8 | PFE |
Pfizer Inc
|
28,268 | $680,693 |
All Filings in NVS
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $214,155 | 1,402 | Shares | Sole | 2026-04-17 | |
| 2023-03-31 | $230,092 | 2,501 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $222,354 | 2,451 | Shares | Sole | 2023-02-01 | |
| 2022-06-30 | $232,542 | 2,751 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $241,400 | 2,751 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $245,003 | 2,801 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $229,065 | 2,801 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $255,563 | 2,801 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $239,429 | 2,801 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $264,498 | 2,801 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $240,705 | 2,768 | Shares | Sole | 2020-10-14 | |
| 2020-06-30 | $241,757 | 2,768 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $228,221 | 2,768 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||